Science
Mechanism of Action
This ingredient functions as a depigmenting agent by activating the synthesis of Dickkopf-1 (DKK-1), an intercellular messenger critical for modulating melanogenesis. DKK-1, in turn, stimulates the Wnt signaling pathway, leading to a measurable reduction in melanin synthesis within melanocytes. Furthermore, it is suggested to confer antioxidant and photoprotective benefits through its activation of the Nrf-2 pathway, contributing to comprehensive skin brightening.
Research
Clinical Evidence
High confidence1%
Key findings
- 01 At a 1% concentration, Inaclear® Vectorized, containing Trimethoxybenzyl Acetylsinapate, demonstrated significant reduction in melanogenesis and dark spots. It enhanced skin brightness, evenness, and radiance by modulating fibroblast synthesis of DKK-1, thereby decreasing melanin production.
Transparency
Dusting Analysis
No specific data regarding dusting characteristics of Trimethoxybenzyl Acetylsinapate was found in the research.
The Formula
Formulation
Stability
When incorporated into the Inaclear® Vectorized formulation, this ingredient exhibits good thermal stability and is not sensitive to heat.
Conflicts
- Cannot be used in clear formulations as it imparts a tint to the batch.
- Requires weak neutralizing agents due to sensitivity during neutralization processes.
Safety
Safety Profile
Trimethoxybenzyl Acetylsinapate has not been reviewed by the Cosmetic Ingredient Review (CIR) panel. There are no reported uses under the FDA's Voluntary Cosmetics Reporting Program. Should the ingredient be utilized in future cosmetic products, the CIR anticipates that data will be provided to support its safety.
Your Skin
Skin Compatibility
Our Assessment
Verdict
Trimethoxybenzyl Acetylsinapate is a valuable active ingredient for precision skincare, demonstrating significant efficacy in skin brightening and dark spot reduction through a well-defined biomimetic mechanism.
Related
Similar Ingredients
Finding similar ingredients…